Predicting type 2 diabetes mellitus: a comparison between the FINDRISC score and the metabolic syndrome.

Meijnikman, Abraham S; De Block, Christophe E M; Verrijken, An; Mertens, Ilse; Van Gaal, Luc F

Meijnikman, Abraham S; De Block, Christophe E M; Verrijken, An; Mertens, Ilse; Van Gaal, Luc F.

Afiliação

Meijnikman AS; Department of Endocrinology, Diabetology & Metabolism, Faculty of Medicine, Antwerp University Hospital and University of Antwerp, Wilrijkstraat 10, 2650 Edegem, Belgium.
De Block CEM; Department of Endocrinology, Diabetology & Metabolism, Faculty of Medicine, Antwerp University Hospital and University of Antwerp, Wilrijkstraat 10, 2650 Edegem, Belgium.
Verrijken A; Department of Endocrinology, Diabetology & Metabolism, Faculty of Medicine, Antwerp University Hospital and University of Antwerp, Wilrijkstraat 10, 2650 Edegem, Belgium.
Mertens I; Department of Endocrinology, Diabetology & Metabolism, Faculty of Medicine, Antwerp University Hospital and University of Antwerp, Wilrijkstraat 10, 2650 Edegem, Belgium.
Van Gaal LF; Department of Endocrinology, Diabetology & Metabolism, Faculty of Medicine, Antwerp University Hospital and University of Antwerp, Wilrijkstraat 10, 2650 Edegem, Belgium.

Diabetol Metab Syndr ; 10: 12, 2018.

Article em En | MEDLINE | ID: mdl-29507612

Palavras-chave

FINDRISC; Metabolic syndrome; Obesity; Prediabetes; Screening; Type 2 diabetes mellitus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diabetol Metab Syndr Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google